Raptor Pharma (RPTP) Tops Q2 EPS by 9c

Raptor Pharma (NASDAQ: RPTP) reported Q2 EPS of ($0.12), $0.09 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c